Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease

Bibliographic Details
Main Authors:	Bilginer Y, Ayvaz N Aktay, Ozen S
Format:	Article
Language:	English
Published:	BMC 2008-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

Behcet Disease: treatment of vascular involvement in children
by: Bilginer Y, et al.
Published: (2008-09-01)

Behçet Disease (BD) in two siblings affected with Familial Mediterranean Fever (FMF)
by: Calcagno G, et al.
Published: (2008-09-01)

Amyloidosis in Behcet′s disease
by: I Ben Ghorbel, et al.
Published: (2015-01-01)

The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease
by: Eitan Giat, et al.
Published: (2022-04-01)

Awareness of FMF among Caregivers
by: Belde Kasap Demir, et al.
Published: (2021-12-01)

Anakinra induces complete remission of nephrotic syndrome in a patient with familial Mediterranean fever and amyloidosis
by: Ángel M. Sevillano, et al.
Published: (2016-01-01)

Familial Mediterranean fever (FMF) in Iran
by: Farhad Salehzadeh, et al.
Published: (2016-04-01)

Screening for Fabry’s disease in a high-risk subpopulation of FMF
by: Tomer Maller, et al.
Published: (2022-10-01)

FMF Genotype-phenotype correlation in Iranian Azeri Turks: Association between M694V/R761H mutation and amyloidosis
by: Morteza Jabbarpour Bonyadi, et al.
Published: (2015-07-01)

Corticosteroid-resistant anakinra-responsive protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever
by: Mustafa Çakan, et al.
Published: (2020-02-01)

The trials of anakinra.
by: Burls, A, et al.
Published: (2004)

Frequency of depression, anxiety, and fatigue in fmf patients and their association with disease parameters
by: Sinem Sag, et al.
Published: (2018-12-01)

Early Disease Onset and Arthritis are Predictors of CKD Development in FMF Patients
by: Refika Büberci, et al.
Published: (2022-07-01)

Patient Experiences and Challenges in the Management of Autoinflammatory Diseases—Data from the International FMF & AID Global Association Survey
by: Jürgen Rech, et al.
Published: (2024-02-01)

Updates on the role of epigenetics in familial mediterranean fever (FMF)
by: Ahlam Chaaban, et al.
Published: (2024-02-01)

Anakinra Therapy for Non-cancer Inflammatory Diseases
by: Giulio Cavalli, et al.
Published: (2018-11-01)

Surgical management of aortic regurgitation secondary to Behcet's disease
by: Hai-Ou Hu, et al.
Published: (2023-03-01)

Hemiballismus Secondary to Neuro-Behçet Disease: Case Report
by: Turgay Demir, et al.
Published: (2014-06-01)

Continuous IV infusion of anakinra
by: Brittney N. Saunders, et al.
Published: (2023-05-01)

Amyloidosis with recurrent oral and peptic ulcers mimicking Behcet's syndrome: A case report
by: Jiajing Peng, et al.
Published: (2022-03-01)

Familial Mediterranean Fever (FMF) before the age of one year
by: Delion F, et al.
Published: (2008-09-01)

Investigation on Beam Expansion Method for Weakly-Coupled FMF Connections
by: Ruiting Cheng, et al.
Published: (2023-01-01)

High prolidase levels in patients with Familial Mediterranean Fever (FMF)
by: Bayram Meliha, et al.
Published: (2020-03-01)

FMF is not always “fever”: from clinical presentation to “treat to target”
by: Maria Cristina Maggio, et al.
Published: (2020-01-01)

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
by: Georges El Hasbani, et al.
Published: (2019-10-01)

Familial Mediterranean Fever (FMF) and renal disease: first report on 29 Sicilian patients
by: Vitale A, et al.
Published: (2008-09-01)

Application of anakinra in inflammatory dermatoses
by: Xiaomei YOU, et al.
Published: (2024-01-01)

Corrigendum: Anakinra Therapy for Non-cancer Inflammatory Diseases
by: Giulio Cavalli, et al.
Published: (2019-03-01)

Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study
by: Micol Romano, et al.
Published: (2022-06-01)

MEFV mutations in systemic JIA
by: Aktay Ayaz N, et al.
Published: (2008-09-01)

Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)
by: Vitale A, et al.
Published: (2008-09-01)

Challenges and insights raised by comorbidity with FMF and selective IgA deficiency
by: Leonardo Oliveira Mendonça, et al.
Published: (2021-12-01)

Dimethylaminoparthenolide (DMAPT) as an alternative approach for treatment of Familial Mediterranean Fever (FMF)
by: Ali Mosayebian, et al.
Published: (2021-10-01)

Behçet Disease
by: Kelly Di Dier, et al.
Published: (2022-11-01)

Behçet disease
by: Ioan Buraga, et al.
Published: (2010-09-01)

BEHÇET’S DISEASE
by: F. Davatchi, et al.
Published: (2005-07-01)

Behçet's disease
by: Saadoun David, et al.
Published: (2012-04-01)

Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
by: Şengül Çaǧlayan, et al.
Published: (2022-08-01)

Behcet's disease in Dagestan
by: L. A. Shamov, et al.
Published: (2004-08-01)

Budget Impact Analysis of anakinra in the treatment of patients with Still’s Disease
by: Roberto Ravasio, et al.
Published: (2020-09-01)